CPIX..Cumberland waiting for the FDA to review their drug for a potential approval with their PDUFA date on 12/10/10. They filed a supplemental drug application with the FDA in the first quarter of the year to expand the label of its liver failure injectable drug Acetadote.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.